Jupiter Asset Management’s Twist Bioscience TWST Stock Holding History

Jupiter Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-243,669	Closed	-$7.73M	–	566
2025 Q4	$7.73M	Sell	243,669 -1,429	-0.6%	-$44.6K	0.06%	235
2025 Q3	$6.9M	Buy	245,098 +192,072	+362%	+$5.82M	0.06%	247
2025 Q2	$1.95M	Buy	+53,026	New	+$1.83M	0.02%	338
2024 Q4	–	Sell	-17,801	Closed	-$804K	–	483
2024 Q3	$804K	Hold	17,801	–	–	0.01%	355
2024 Q2	$877K	Sell	17,801 -6,933	-28%	-$283K	0.01%	341
2024 Q1	$849K	Hold	24,734	–	–	0.01%	374
2023 Q4	$912K	Hold	24,734	–	–	0.01%	390
2023 Q3	$501K	Sell	24,734 -46,881	-65%	-$1.03M	0.01%	433
2023 Q2	$1.47M	Buy	+71,615	New	+$1.07M	0.02%	401

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Asset Management's TWST Position: Q1 2026 in Review

Jupiter Asset Management sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 243,669 shares — an estimated $7.73M sold.

Jupiter Asset Management first reported a position in TWST in Q2 2023 and held it in 9 quarters. The position peaked at $7.73M in Q4 2025. 281 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

Jupiter Asset Management reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
Jupiter Asset Management sold 243,669 Twist Bioscience shares in Q1 2026, an estimated $7.73M.
Jupiter Asset Management first reported a position in Twist Bioscience in Q2 2023 and held it in 9 quarters.
Jupiter Asset Management's Twist Bioscience position peaked at $7.73M in Q4 2025.
281 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Jupiter Asset Management's 13F filing for Q1 2026, filed 12 May 2026.